We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.59%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$10.2B
AUM Growth
+$2.21B
(+28%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
18.7%
Top 10 Holdings %
Top 10 Hldgs %
42.15%
Holding
2,326
New
523
Increased
761
Reduced
552
Closed
381
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$88.6M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$55.2M |
| 3 |
Amazon
AMZN
|
+$50.7M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.4M |
| 5 |
Apple
AAPL
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$30.4M |
| 2 |
Wells Fargo
WFC
|
+$18.1M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$13.9M |
| 4 |
STJ
St Jude Medical
STJ
|
+$13.5M |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$13.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 4.46% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.69% |
| 4 | Healthcare | 3.55% |
| 5 | Technology | 3.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
REX American Resources
REX
$1.44B
| $344K | ﹤0.01% |
+20,898
| New | +$310K |
|
1652
CALL
Inovio Pharmaceuticals
INO
$79.4M
| $341K | ﹤0.01% |
4,092
-75
| -2% | -$6.78K |
|
1653
Pultegroup
PHM
$24.9B
| $338K | ﹤0.01% |
18,390
+3,613
| +24% | +$68.6K |
|
|
GNC
1654
DELISTED
GNC Holdings, Inc.
GNC
| $337K | ﹤0.01% |
30,488
-24,203
| -44% | -$379K |
|
|
ABCO
1655
DELISTED
Advisory Board Co
ABCO
| $335K | ﹤0.01% |
+10,067
| New | +$372K |
|
1656
Adeia
ADEA
$2.88B
| $334K | ﹤0.01% |
28,550
-79,010
| -73% | -$838K |
|
|
ATW
1657
DELISTED
Atwood Oceanics
ATW
| $334K | ﹤0.01% |
25,406
+13,506
| +113% | +$133K |
|
|
HK
1658
DELISTED
Halcon Resources Corporation
HK
| $334K | ﹤0.01% |
+35,710
| New | +$336K |
|
|
TGH
1659
DELISTED
Textainer Group Holdings limited
TGH
| $333K | ﹤0.01% |
+44,694
| New | +$371K |
|
|
HMSY
1660
DELISTED
HMS Holdings Corp.
HMSY
| $333K | ﹤0.01% |
18,364
-9,436
| -34% | -$184K |
|
1661
LiveRamp
RAMP
$2.3B
| $329K | ﹤0.01% |
+12,276
| New | +$319K |
|
|
AKRX
1662
DELISTED
Akorn Inc
AKRX
| $329K | ﹤0.01% |
+15,073
| New | +$347K |
|
|
ODP
1663
DELISTED
ODP
ODP
| $328K | ﹤0.01% |
7,263
+1,429
| +24% | +$59.2K |
|
1664
First Solar
FSLR
$22.1B
| $327K | ﹤0.01% |
10,200
-5,746
| -36% | -$202K |
|
1665
Louisiana-Pacific
LPX
$5.19B
| $326K | ﹤0.01% |
17,224
-30,400
| -64% | -$580K |
|
1666
Essent Group
ESNT
$6.12B
| $324K | ﹤0.01% |
+10,000
| New | +$294K |
|
1667
Methanex
MEOH
$4.19B
| $324K | ﹤0.01% |
+7,407
| New | +$296K |
|
1668
Clean Harbors
CLH
$15.9B
| $323K | ﹤0.01% |
+5,807
| New | +$293K |
|
1669
iShares MSCI Hong Kong ETF
EWH
$1.23B
| $323K | ﹤0.01% |
+16,582
| New | +$348K |
|
|
TWTR
1670
DELISTED
Twitter, Inc.
TWTR
| $323K | ﹤0.01% |
19,834
-197,112
| -91% | -$3.61M |
|
|
SEM
1671
DELISTED
Select Medical
SEM
| $322K | ﹤0.01% |
+45,173
| New | +$314K |
|
1672
AutoNation
AN
$7.1B
| $317K | ﹤0.01% |
6,512
+267
| +4% | +$12.4K |
|
|
SCLN
1673
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $315K | ﹤0.01% |
+29,188
| New | +$292K |
|
1674
Automatic Data Processing
ADP
$102B
| $313K | ﹤0.01% |
3,035
-27,605
| -90% | -$2.58M |
|
1675
MACOM Technology Solutions
MTSI
$20.1B
| $310K | ﹤0.01% |
+6,699
| New | +$293K |
|
Similar funds
JF
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
Paloma Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Paloma Partners held 2,326 positions worth $10.2B, up 28% from $7.99B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Paloma Partners deployed $1.91B of net new capital in Q4 2016, opening 523 new positions and adding to 761 existing holdings. Its largest new stake was NXP Semiconductors: 253,000 shares worth $24.8M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 4.5% of assets, up from 3.4% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was KLA, an estimated $30.4M trimmed.
- Paloma Partners's largest Q4 2016 buy was NXP Semiconductors: 253,000 shares worth $24.8M.
- Paloma Partners added most to Biogen in Q4 2016, an estimated $88.6M increase.
- Paloma Partners's biggest Q4 2016 reduction was KLA, cutting an estimated $30.4M.
- Paloma Partners fully exited St Jude Medical in Q4 2016, selling an estimated $13.5M.
- Paloma Partners's ten largest holdings make up 42% of its $10.2B portfolio in Q4 2016.
- Paloma Partners opened 523 new positions and closed 381 in Q4 2016.
- Paloma Partners's portfolio value rose 28% quarter-over-quarter to $10.2B.
Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.